Agency Forms Undergoing Paperwork Reduction Act Review, 7715-7717 [2024-02171]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 24 / Monday, February 5, 2024 / Notices
lotter on DSK11XQN23PROD with NOTICES1
Counselors, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
Constitution Center, 400 7th Street SW,
Suite 5W, Washington, District of
Columbia 20024. Telephone: (202) 245–
0649; Email: MStrickland2@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Secretary of Health
and Human Services, the Assistant
Secretary for Health, and by delegation
the Director, Centers for Disease Control
and Prevention, are authorized under
Sections 301 and 308 of the Public
Health Service Act to conduct directly,
or by grants or contracts, research,
experiments, and demonstrations
relating to occupational safety and
health and to mine health.
Purpose: The Board of Scientific
Counselors, National Institute for
Occupational Safety and Health (BSC,
NIOSH) provides advice to the Director,
National Institute for Occupational
Safety and Health, on NIOSH research
and prevention programs. The Board
also provides guidance on the Institute’s
research activities related to developing
and evaluating hypotheses,
systematically documenting findings,
and disseminating results. In addition,
the Board evaluates the degree to which
the activities of NIOSH: (1) conform to
those standards of scientific excellence
appropriate for Federal scientific
institutions in accomplishing objectives
in occupational safety and health; (2)
address currently relevant needs in the
fields of occupational safety and health
either alone or in conjunction with
other known activities inside and
outside of NIOSH; and (3) produce their
intended results in addressing
important research questions in
occupational safety and health, both in
terms of applicability of the research
findings and dissemination of the
findings.
Matters To Be Considered: The agenda
for the meeting addresses the NIOSH
Evaluation Capacity Building Plan (ECB
Plan) and Scoring Progress on the ECB
Plan; Diversity, Equity, and Inclusion at
NIOSH; and a National Firefighter
Registry Subcommittee Update. Agenda
items are subject to change as priorities
dictate.
The agenda is also posted on the
NIOSH website at https://www.cdc.gov/
niosh/bsc/.
Public Participation
Written Public Comment: Written
comments will be accepted per the
instructions provided in the addresses
section above. Comments received in
advance of the meeting are part of the
public record and are subject to public
disclosure. Written comments will be
VerDate Sep<11>2014
17:56 Feb 02, 2024
Jkt 262001
included in the official record of the
meeting. Do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near-duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
Written comments received by March
6, 2024, will be provided to the Board
prior to the meeting.
Oral Public Comment: The public is
welcome to participate during the
public comment period, from 1 p.m. to
1:15 p.m., EDT, March 13, 2024. Each
commenter will be provided up to five
minutes for comment. A limited number
of time slots are available and will be
assigned on a first-come, first-served
basis. Members of the public who wish
to address the BSC, NIOSH are
requested to contact the Designated
Federal Officer for scheduling purposes
(see FOR FURTHER INFORMATION CONTACT
above).
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–02180 Filed 2–2–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–24–0728]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
7715
has submitted the information
collection request titled ‘‘National
Notifiable Diseases Surveillance System
(NNDSS)’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on November
14, 2023 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
E:\FR\FM\05FEN1.SGM
05FEN1
7716
Federal Register / Vol. 89, No. 24 / Monday, February 5, 2024 / Notices
Proposed Project
National Notifiable Diseases
Surveillance System (NNDSS) (OMB
Control No. 0920–0728, Exp. 03/31/
2026)—Revision—Office of Public
Health Data, Surveillance, and
Technology (OPHDST), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Public Health Services Act (42
U.S.C. 241) authorizes CDC to
disseminate nationally notifiable
condition information. The National
Notifiable Diseases Surveillance System
(NNDSS) is based on data collected at
the state, territorial and local levels
because of legislation and regulations in
those jurisdictions that require health
care providers, medical laboratories,
and other entities to submit healthrelated data on reportable conditions to
public health departments. These
reportable conditions, which include
infectious and non-infectious diseases,
vary by jurisdiction depending upon
each jurisdiction’s health priorities and
needs. Each year, the Council of State
and Territorial Epidemiologists (CSTE),
supported by CDC, determines which
reportable conditions should be
designated nationally notifiable or
under standardized surveillance. CDC
requests a three-year approval for a
Revision of the NNDSS (OMB Control
No. 0920–0728, Exp. Date 03/31/2026).
This Revision includes requests for
approval to: (1) receive case notification
data for Cronobacter and Ehrlichiosis,
new notifiable conditions; (2) receive
case notification data for Congenital
cytomegalovirus infection and
Toxoplasmosis, new conditions under
standardized surveillance; and (3)
receive new disease-specific data
elements for Cronobacter, Hansen’s
Disease (Leprosy), and Leptospirosis.
The NNDSS currently facilitates the
submission and aggregation of case
notification data voluntarily submitted
to CDC from 60 jurisdictions: public
health departments in every U.S. state,
New York City, Washington DC, five
U.S. territories (American Samoa, the
Commonwealth of Northern Mariana
Islands, Guam, Puerto Rico, and the U.S.
Virgin Islands), and three freely
associated states (Federated States of
Micronesia, the Republic of the
Marshall Islands, and the Republic of
Palau). This information is shared
across jurisdictional boundaries and
both surveillance and prevention and
control activities are coordinated at
regional and national levels.
Approximately 90% of case
notifications are encrypted and
submitted to NNDSS electronically from
already existing databases by automated
electronic messages. When automated
transmission is not possible, case
notifications are faxed, emailed,
uploaded to a secure network or entered
into a secure website. All case
notifications that are faxed or emailed
are done so in the form of an aggregate
weekly or annual report, not individual
cases. These different mechanisms used
to send case notifications to CDC vary
by the jurisdiction and the disease or
condition. Jurisdictions remove most
personally identifiable information (PII)
before data are submitted to CDC, but
some data elements (e.g., date of birth,
date of diagnosis, county of residence)
could potentially be combined with
other information to identify
individuals. Private information is not
disclosed unless otherwise compelled
by law. All data are treated in a secure
manner consistent with the technical,
administrative, and operational controls
required by the Federal Information
Security Management Act of 2002
(FISMA) and the 2010 National Institute
of Standards and Technology (NIST)
Recommended Security Controls for
Federal Information Systems and
Organizations. Weekly tables of
nationally notifiable diseases are
available through CDC WONDER and
data.cdc.gov. Annual summaries of
finalized nationally notifiable disease
data are published on CDC WONDER
and data.cdc.gov and disease-specific
data are published by individual CDC
programs.
The burden estimates include the
number of hours that the public health
department uses to process and send
case notification data from their
jurisdiction to CDC. Specifically, the
burden estimates include separate
burden hours incurred for automated
and non-automated transmissions,
separate weekly burden hours incurred
for modernizing surveillance systems as
part of CDC’s Data Modernization
Initiative (DMI) implementation,
separate burden hours incurred for
annual data reconciliation and
submission, and separate one-time
burden hours incurred for the addition
of new diseases and data elements. The
burden estimates for the one-time
burden for reporting jurisdictions are for
the addition of case notification data for
Cronobacter and Ehrlichiosis, new
notifiable conditions; the addition of
case notification data for Congenital
cytomegalovirus infection and
Toxoplasmosis, new conditions under
standardized surveillance; and the
addition of new disease-specific data
elements for Cronobacter, Hansen’s
Disease (Leprosy) and Leptospirosis.
The estimated annual burden for the
257 respondents is 18,414 hours. The
total burden hours decreased from
18,594 to 18,414 since the last Revision
because there were fewer diseasespecific data elements added compared
to the previous Revision. There are no
costs to respondents other than their
time to participate.
lotter on DSK11XQN23PROD with NOTICES1
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
States ............................................
States ............................................
States ............................................
States ............................................
States ............................................
Territories ......................................
Territories ......................................
Territories ......................................
Territories ......................................
Territories ......................................
Freely Associated States ..............
Freely Associated States ..............
Freely Associated States ..............
Freely Associated States ..............
Weekly (Automated) .........................................................
Weekly (Non-automated) ..................................................
Weekly (DMI Implementation) ..........................................
Annual ...............................................................................
One-time Addition of Diseases and Data Elements ........
Weekly (Automated) .........................................................
Weekly, Quarterly (Non-automated) .................................
Weekly (DMI Implementation) ..........................................
Annual ...............................................................................
One-time Addition of Diseases and Data Elements ........
Weekly (Automated) .........................................................
Weekly, Quarterly (Non-automated) .................................
Annual ...............................................................................
One-time Addition of Diseases and Data Elements ........
VerDate Sep<11>2014
17:56 Feb 02, 2024
Jkt 262001
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
E:\FR\FM\05FEN1.SGM
50
10
50
50
50
5
5
5
5
5
3
3
3
3
05FEN1
Number of
responses per
respondent
52
52
52
1
1
52
56
52
1
1
52
56
1
1
Average
burden per
response
(in hours)
20/60
2
4
75
3
20/60
20/60
4
5
3
20/60
20/60
5
3
7717
Federal Register / Vol. 89, No. 24 / Monday, February 5, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent
Cities
Cities
Cities
Cities
Cities
.............................................
.............................................
.............................................
.............................................
.............................................
Weekly (Automated) .........................................................
Weekly (Non-automated) ..................................................
Weekly (DMI Implementation) ..........................................
Annual ...............................................................................
One-time Addition of Diseases and Data Elements ........
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–02171 Filed 2–2–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—CE24–011,
Grants To Support New Investigators
in Conducting Research Related To
Understanding Drug Use and
Overdose Risk and Protective Factors
(K01); Cancellation of Meeting
Centers for Disease Control and
Prevention, Department of Health and
Human Services.
AGENCY:
ACTION:
Notice.
FOR FURTHER INFORMATION CONTACT:
Aisha L. Wilkes, M.P.H., Scientific
Review Officer, National Center for
Injury Prevention and Control, Centers
for Disease Control and Prevention,
4770 Buford Highway NE, Mailstop
S106–9, Atlanta, Georgia 30341–3717.
Telephone: (404) 639–6473; Email:
AWilkes@cdc.gov.
Notice is
hereby given of a change in the meeting
of the Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—CE24–011,
Grants to Support New Investigators in
Conducting Research Related to
Understanding Drug Use and Overdose
Risk and Protective Factors (K01);
Cancellation of Meeting; March 5, 2024,
8:30 a.m.–5 p.m., EST., in the original
Federal Register notice FRN. The web
conference was published in the
Federal Register on Tuesday, October
24, 2023, 88 FR 73020.
This meeting is being canceled in its
entirety.
lotter on DSK11XQN23PROD with NOTICES1
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:56 Feb 02, 2024
Jkt 262001
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–02208 Filed 2–2–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-24–0696; Docket No. CDC–2024–
0006]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled National HIV
Prevention Program Monitoring and
Evaluation (NHM&E). NHM&E collects
standardized HIV prevention program
evaluation data from health departments
and community-based organizations
(CBOs) who receive federal funds for
HIV prevention activities.
SUMMARY:
PO 00000
Frm 00036
Fmt 4703
Number of
responses per
respondent
Number of
respondents
Form name
Sfmt 4703
2
2
2
2
2
52
52
52
1
1
Average
burden per
response
(in hours)
20/60
2
4
75
3
CDC must receive written
comments on or before April 5, 2024.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2024–
0006 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7118; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
DATES:
E:\FR\FM\05FEN1.SGM
05FEN1
]]>Agencies
[Federal Register Volume 89, Number 24 (Monday, February 5, 2024)]
[Notices]
[Pages 7715-7717]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02171]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-24-0728]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``National Notifiable Diseases Surveillance
System (NNDSS)'' to the Office of Management and Budget (OMB) for
review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
November 14, 2023 to obtain comments from the public and affected
agencies. CDC received one comment related to the previous notice. This
notice serves to allow an additional 30 days for public and affected
agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
[[Page 7716]]
Proposed Project
National Notifiable Diseases Surveillance System (NNDSS) (OMB
Control No. 0920-0728, Exp. 03/31/2026)--Revision--Office of Public
Health Data, Surveillance, and Technology (OPHDST), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The Public Health Services Act (42 U.S.C. 241) authorizes CDC to
disseminate nationally notifiable condition information. The National
Notifiable Diseases Surveillance System (NNDSS) is based on data
collected at the state, territorial and local levels because of
legislation and regulations in those jurisdictions that require health
care providers, medical laboratories, and other entities to submit
health-related data on reportable conditions to public health
departments. These reportable conditions, which include infectious and
non-infectious diseases, vary by jurisdiction depending upon each
jurisdiction's health priorities and needs. Each year, the Council of
State and Territorial Epidemiologists (CSTE), supported by CDC,
determines which reportable conditions should be designated nationally
notifiable or under standardized surveillance. CDC requests a three-
year approval for a Revision of the NNDSS (OMB Control No. 0920-0728,
Exp. Date 03/31/2026). This Revision includes requests for approval to:
(1) receive case notification data for Cronobacter and Ehrlichiosis,
new notifiable conditions; (2) receive case notification data for
Congenital cytomegalovirus infection and Toxoplasmosis, new conditions
under standardized surveillance; and (3) receive new disease-specific
data elements for Cronobacter, Hansen's Disease (Leprosy), and
Leptospirosis.
The NNDSS currently facilitates the submission and aggregation of
case notification data voluntarily submitted to CDC from 60
jurisdictions: public health departments in every U.S. state, New York
City, Washington DC, five U.S. territories (American Samoa, the
Commonwealth of Northern Mariana Islands, Guam, Puerto Rico, and the
U.S. Virgin Islands), and three freely associated states (Federated
States of Micronesia, the Republic of the Marshall Islands, and the
Republic of Palau). This information is shared across jurisdictional
boundaries and both surveillance and prevention and control activities
are coordinated at regional and national levels.
Approximately 90% of case notifications are encrypted and submitted
to NNDSS electronically from already existing databases by automated
electronic messages. When automated transmission is not possible, case
notifications are faxed, emailed, uploaded to a secure network or
entered into a secure website. All case notifications that are faxed or
emailed are done so in the form of an aggregate weekly or annual
report, not individual cases. These different mechanisms used to send
case notifications to CDC vary by the jurisdiction and the disease or
condition. Jurisdictions remove most personally identifiable
information (PII) before data are submitted to CDC, but some data
elements (e.g., date of birth, date of diagnosis, county of residence)
could potentially be combined with other information to identify
individuals. Private information is not disclosed unless otherwise
compelled by law. All data are treated in a secure manner consistent
with the technical, administrative, and operational controls required
by the Federal Information Security Management Act of 2002 (FISMA) and
the 2010 National Institute of Standards and Technology (NIST)
Recommended Security Controls for Federal Information Systems and
Organizations. Weekly tables of nationally notifiable diseases are
available through CDC WONDER and data.cdc.gov. Annual summaries of
finalized nationally notifiable disease data are published on CDC
WONDER and data.cdc.gov and disease-specific data are published by
individual CDC programs.
The burden estimates include the number of hours that the public
health department uses to process and send case notification data from
their jurisdiction to CDC. Specifically, the burden estimates include
separate burden hours incurred for automated and non-automated
transmissions, separate weekly burden hours incurred for modernizing
surveillance systems as part of CDC's Data Modernization Initiative
(DMI) implementation, separate burden hours incurred for annual data
reconciliation and submission, and separate one-time burden hours
incurred for the addition of new diseases and data elements. The burden
estimates for the one-time burden for reporting jurisdictions are for
the addition of case notification data for Cronobacter and
Ehrlichiosis, new notifiable conditions; the addition of case
notification data for Congenital cytomegalovirus infection and
Toxoplasmosis, new conditions under standardized surveillance; and the
addition of new disease-specific data elements for Cronobacter,
Hansen's Disease (Leprosy) and Leptospirosis. The estimated annual
burden for the 257 respondents is 18,414 hours. The total burden hours
decreased from 18,594 to 18,414 since the last Revision because there
were fewer disease-specific data elements added compared to the
previous Revision. There are no costs to respondents other than their
time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
States................................ Weekly (Automated)...... 50 52 20/60
States................................ Weekly (Non-automated).. 10 52 2
States................................ Weekly (DMI 50 52 4
Implementation).
States................................ Annual.................. 50 1 75
States................................ One-time Addition of 50 1 3
Diseases and Data
Elements.
Territories........................... Weekly (Automated)...... 5 52 20/60
Territories........................... Weekly, Quarterly (Non- 5 56 20/60
automated).
Territories........................... Weekly (DMI 5 52 4
Implementation).
Territories........................... Annual.................. 5 1 5
Territories........................... One-time Addition of 5 1 3
Diseases and Data
Elements.
Freely Associated States.............. Weekly (Automated)...... 3 52 20/60
Freely Associated States.............. Weekly, Quarterly (Non- 3 56 20/60
automated).
Freely Associated States.............. Annual.................. 3 1 5
Freely Associated States.............. One-time Addition of 3 1 3
Diseases and Data
Elements.
[[Page 7717]]
Cities................................ Weekly (Automated)...... 2 52 20/60
Cities................................ Weekly (Non-automated).. 2 52 2
Cities................................ Weekly (DMI 2 52 4
Implementation).
Cities................................ Annual.................. 2 1 75
Cities................................ One-time Addition of 2 1 3
Diseases and Data
Elements.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-02171 Filed 2-2-24; 8:45 am]
BILLING CODE 4163-18-P
